Market Overview

Allergan Rallies Ahead Of Q1 Report


Allergan (NYSE: AGN) shares are trading higher by $13 at $214.65 in Monday's session. The company will announce Q1 earnings before the bell on Tuesday.

The issue has tumbled since a planned merger with Pfizer Inc (NYSE: PFE) was scrapped on April 5. The following day drop declined all the way to $236.55 and traded as low as $195.50 in before rebounding to close at $201.65.

The catalyst for today's rally besides some short covering ahead of the report is the announcement that a Phase III study for Ulipristal Acetate in the treatment of uterine fibroids met all co-primary and secondary endpoints.

Posted-In: Technicals Intraday Update Movers Trading Ideas


Related Articles (AGN + PFE)

View Comments and Join the Discussion!

Dealogic: 2016 Has Already Seen Failed U.S. Deals Worth $378 Billion

Quality Works For This Emerging Markets ETF